ADAR2 acts as a novel proviral factor for HIV-1 by enhancing the release of progeny virions, though it does not increase viral infectious potential.
No takes yet. Share an insight, caveat, or question.
ADAR2 may support antiviral strategies targeting HIV-1 release; leaves open clinical translation pending in vivo validation.
Doria et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: